Zydus Lifesciences Ltd said on August 13 that the US Food and Drug Administration (USFDA) has wrapped up a surveillance inspection at its formulation manufacturing plant in Baddi, Himachal Pradesh.

The CCPS will be converted into equity shares of ABDFVL as per the conversion terms defined in the shareholders’ agreement.

Compared to the May survey, the July survey shows household perception of current inflation down 50 bps from 7.7% to 7.2%.

The contract is valued at ₹90.65 crore and will be executed over a period of 18 months under general contract conditions.

In July 2025, passive funds saw better traction in flows but strong price depletion.

GROSS CHURN BY MUTUAL FUNDS IN JULY 2025. July 2025 saw domestic equity funds net inflows of ₹42,702 Crore; 81% above the ...

The business said that its revenue for the quarter jumped as much as 66% to ₹3,365 Crore against the previous corresponding ...

The company has filed its draft red herring prospectus (DRHP) with the SEBI for an initial public offering valued at ₹4,900 ...

As per the company’s filing with the bourses, the two companies will collaborate for the development of the green ammonia facility.

The company announced an EBITDA of ₹206 Crore. This was down by 4.6% against the same quarter of previous year.

The funding will be used for the development of a 280 MW Firm and Dispatchable Renewable Energy (FDRE) project contracted with NHPC Ltd.

The company hit an exceptional loss of ₹17.14 crore in Q1 FY26 on account of the damage caused by the April fire at the ...